Temozolomide and pituitary adenoma

被引：0
|
作者：
Hueng, Dueng-Yuan [1 ,2 ]
Ma, Hsin-I [1 ,2 ]
Sytwu, Huey-Kang [1 ,2 ]
Liu, Ming-Ying [1 ]
机构：
[1] Triserv Gen Hosp, Taipei, Taiwan
[2] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan
来源：
JOURNAL OF NEUROSURGERY | 2011年 / 114卷 / 06期
关键词：
D O I：
10.3171/2011.3.JNS11361
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1820 / 1820
页数：1
相关论文
共 50 条
  • [1] Treatment of a refractory pituitary adenoma with temozolomide and literature review
    马四海
    China Medical Abstracts(Surgery), 2011, 20 (03) : 214 - 214
  • [2] Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
    Luis V. Syro
    Bernd W. Scheithauer
    Leon D. Ortiz
    Camilo E. Fadul
    Eva Horvath
    Fabio Rotondo
    Kalman Kovacs
    Hormones, 2009, 8 : 303 - 306
  • [3] Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
    Syro, Luis V.
    Scheithauer, Bernd W.
    Ortiz, Leon D.
    Fadul, Camilo E.
    Horvath, Eva
    Rotondo, Fabio
    Kovacs, Kalman
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2009, 8 (04): : 303 - 306
  • [4] Temozolomide: A Useful Treatment for an Aggressive ACTH Secreting Pituitary Adenoma
    Lugli, Francesca
    Iacovazzo, Donato
    Piacentini, Serena
    Bianchi, Antonio
    Giampietro, Antonella
    Doglietto, Francesco
    Balducci, Mario
    Lauriola, Libero
    Maira, Giulio
    Pontecorvi, Alfredo
    De Marinis, Laura
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [5] Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide
    Matsuno, Akira
    Murakami, Mineko
    Hoya, Katsumi
    Yamada, Shoko M.
    Miyamoto, Shinya
    Yamada, So
    Son, Jae-Hyun
    Nishido, Hajime
    Ide, Fuyuaki
    Nagashima, Hiroshi
    Sugaya, Mutsumi
    Hirohata, Toshio
    Mizutani, Akiko
    Okinaga, Hiroko
    Ishii, Yudo
    Tahara, Shigeyuki
    Teramoto, Akira
    Osamura, R. Yoshiyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (01) : 1 - 7
  • [6] Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide
    Akira Matsuno
    Mineko Murakami
    Katsumi Hoya
    Shoko M. Yamada
    Shinya Miyamoto
    So Yamada
    Jae-Hyun Son
    Hajime Nishido
    Fuyuaki Ide
    Hiroshi Nagashima
    Mutsumi Sugaya
    Toshio Hirohata
    Akiko Mizutani
    Hiroko Okinaga
    Yudo Ishii
    Shigeyuki Tahara
    Akira Teramoto
    R. Yoshiyuki Osamura
    Medical Molecular Morphology, 2014, 47 : 1 - 7
  • [7] Non-uniform Response to Temozolomide Therapy in a Pituitary Gonadotroph Adenoma
    Ersen, Ayca
    Syro, Luis V.
    Penagos, Luis C.
    Uribe, Humberto
    Scheithauer, Bernd W.
    Ortiz, Leon D.
    Rotondo, Fabio
    Horvath, Eva
    Kovacs, Kalman
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2012, 39 (05) : 683 - 685
  • [8] Temozolomide-induced inhibition of pituitary adenoma cells Laboratory investigation
    Sheehan, Jason
    Rainey, Jessica
    Nguyen, James
    Grimsdale, Ruthie
    Han, Shaojie
    JOURNAL OF NEUROSURGERY, 2011, 114 (02) : 354 - 358
  • [9] Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
    Filippo Ceccato
    Giuseppe Lombardi
    Renzo Manara
    Enzo Emanuelli
    Luca Denaro
    Laura Milanese
    Marina Paola Gardiman
    Roberta Bertorelle
    Massimo Scanarini
    Domenico D’Avella
    Gianluca Occhi
    Marco Boscaro
    Vittorina Zagonel
    Carla Scaroni
    Journal of Neuro-Oncology, 2015, 122 : 189 - 196
  • [10] Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
    Ceccato, Filippo
    Lombardi, Giuseppe
    Manara, Renzo
    Emanuelli, Enzo
    Denaro, Luca
    Milanese, Laura
    Gardiman, Marina Paola
    Bertorelle, Roberta
    Scanarini, Massimo
    D'Avella, Domenico
    Occhi, Gianluca
    Boscaro, Marco
    Zagonel, Vittorina
    Scaroni, Carla
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 189 - 196
12345